• Machine Learning-Driven LNP Design for Microglial mRNA Deliv

  2026-07-20

  This study integrates supervised machine learning with high-throughput screening to optimize lipid nanoparticle (LNP) formulations for mRNA delivery targeting pro-inflammatory microglia. The approach identifies immunomodulatory LNPs capable of repolarizing activated microglia, with implications for neuroinflammatory disorder therapies.

• Metoprolol Tartrate: β1-Adrenergic Blocking in Cardiovascula

  2026-07-20

  Metoprolol Tartrate distinguishes itself as a precision β1-adrenergic blocking agent, ideal for dissecting receptor-specific pathways in cardiovascular and hematopoietic research. Its selectivity, solubility, and validated performance in post-HCT models make it a first-choice tool for translational investigators.

• Acetylspiramycin (Spiramycin B): Advanced Antimicrobial Assa

  2026-07-19

  Acetylspiramycin (Spiramycin B) enables robust workflows for antimicrobial resistance research, with unique advantages against macrolide-resistant pathogens and immunomodulatory insights. Learn how to optimize susceptibility testing, troubleshoot solubility, and leverage genetic advances in macrolide biosynthesis.

• Nifedipine (BAY-a-1040): Decoding Calcium Blockade in Hepati

  2026-07-18

  Explore how Nifedipine (BAY-a-1040) enables precise calcium influx inhibition across hepatic and cardiac research. This article uniquely dissects mechanistic insights and experimental protocols, leveraging recent advances in PXR-driven metabolic regulation to inform advanced assay design.

• Repurposing FDA-Approved Drugs to Guide DNA Repair in CRISPR

  2026-07-17

  This study systematically screens over 7,000 FDA-approved compounds to map their influence on DNA double-strand break repair pathway choice in human stem cells during CRISPR genome editing. The findings provide actionable guidance for precision genome engineering, synthetic lethality strategies, and disease modeling by pharmacologically steering DNA repair mechanisms.

• lncRNA HITT Attenuates ATM Activation and Sensitizes Cancer

  2026-07-17

  This study uncovers a direct regulatory role for the long noncoding RNA HITT in suppressing ATM kinase activation, thereby impeding homologous recombination repair and enhancing cancer cell sensitivity to genotoxic therapies. The findings offer mechanistic insight into how noncoding RNAs can modulate DNA damage response pathways and suggest new strategies for radiosensitization.

• RBMS1 Loss Enhances Immunity in Triple-Negative Breast Cance

  2026-07-16

  The referenced study uncovers a novel immunoregulatory mechanism in triple-negative breast cancer (TNBC) by identifying RBMS1 as a key post-transcriptional stabilizer of PD-L1 via B4GALT1. Depletion of RBMS1 destabilizes B4GALT1 mRNA, reduces PD-L1 glycosylation and stability, and sensitizes tumors to immune checkpoint blockade, offering a promising target for combinatorial cancer immunotherapy strategies.

• Cefazedone (Refosporen): Applied Protocols in Antibacterial

  2026-07-16

  Cefazedone (Refosporen) empowers robust, β-lactamase-resistant workflows for both in vitro and in vivo antibacterial research targeting challenging Gram-positive and Gram-negative pathogens. This article synthesizes the latest pharmacokinetic innovations, experimental protocols, and troubleshooting strategies to optimize your antibacterial testing pipeline with APExBIO’s trusted reagent.

• 4μ8C as a Precision Tool for Decoding ER Stress and Protein

  2026-07-15

  Explore how 4μ8C (7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde) enables precise dissection of ER stress signaling, linking IRE1α inhibition to advances in ADP-ribosylation research. This article uniquely bridges mechanistic UPR studies and protein degradation pathways for cancer research.

• Eltanexor (KPT-8602): Redefining Nuclear Export in Translati

  2026-07-15

  Eltanexor (KPT-8602) represents a transformative advance in the targeting of nuclear export for cancer therapeutics. This article unpacks the mechanistic rationale, pivotal preclinical data, and strategic imperatives for translational researchers leveraging Eltanexor in hematological and solid tumor models. With a focus on the emerging impact of XPO1 inhibition in pathways such as Wnt/β-catenin signaling and chemoprevention, this piece moves beyond conventional product reviews, providing a forward-looking perspective on how Eltanexor can accelerate discovery and clinical translation.

• Prenatal Esketamine Impairs Neurogenesis: 5-EdU Assay Insigh

  2026-07-14

  A recent study reveals that prenatal exposure to esketamine leads to impaired neurogenesis and neurobehavioral deficits in rat offspring, using 5-Ethynyl-2'-deoxyuridine (5-EdU) labeling to assess proliferative capacity. These findings raise critical considerations for the safety of anesthetic use during pregnancy and highlight advanced cell proliferation assays for neurodevelopmental research.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Precisi

  2026-07-14

  Explore the unique capabilities of 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) for next-generation nucleic acid delivery. This article delivers a deep dive into its mechanism, protocol optimization, and translational applications, offering new insights that extend beyond previous literature.

• CARM1-Targeted Peptide Inhibition Suppresses Breast Cancer P

  2026-07-13

  A novel peptide inhibitor selectively targeting CARM1 was shown to suppress breast cancer cell proliferation and tumor growth both in vitro and in vivo. The findings highlight a promising therapeutic avenue for overcoming endocrine resistance in estrogen receptor-positive breast cancer and offer new mechanistic insights into epigenetic regulation of tumorigenesis.

• Cardamomin Mitigates Oxidative Damage in Ischemic Stroke Mod

  2026-07-13

  This study reveals that cardamomin, a chalcone from Amomum villosum, protects neural tissue from oxidative damage and reduces infarct size in models of cerebral ischemic stroke. The research elucidates specific molecular mechanisms—particularly NRF2 pathway activation and cell death pathway modulation—offering preclinical insights for neuroprotection strategies.

• Schizophrenia GWAS Loci Reveal Divergent Pathways in Neuron

  2026-07-12

  Liu et al. reveal that schizophrenia-associated genetic variants converge on different molecular pathways in developing cortical interneurons versus glutamatergic neurons, using homogeneous human iPSC-derived cell populations. This cell type-specific resolution provides mechanistic insight into how schizophrenia risk genes impact brain development and offers direction for targeted therapeutic research.

454 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page